Carisma Therapeutics Inc Share Price

NASDAQ: CARM

Small Cap

$0.32

-0.02

(-4.96%)

as on September 18, 2025 at 1:29 am IST

$₹

Carisma Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$0.31
Day's Price Range
$0.34
$0.32
3.13%
Downside
6.25%
Upside
52 Week's Low
52 Week's High
$0.14
52-Week Price Range
$1.27
$0.32
55.72%
Downside
296.88%
Upside

Carisma Therapeutics Inc share price movements today

Previous Close: $0.34
Open: $0.33
Volume: 993.1K
Day's Low - High: $0.31 - $0.34
52 Week Low - High: $0.14 - $1.27

Carisma Therapeutics Inc Historical Returns

1 Month Return: + 15.24 %
3 Month Return: -25.22 %
1 Year Return: -66.35 %
3 Year Return: 0 %
5 Year Return: 0 %

Carisma Therapeutics Inc Stock Fundamentals & Key Indicators

Check Carisma Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.5M

EPS (TTM)

-0.69

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.62

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-42.0M

Revenue (TTM)

10.8M

Profit Margin

0.00%

Return On Equity TTM

4160800.00%

Carisma Therapeutics Inc Stock Valuation

Track how Carisma Therapeutics Inc P/E has moved over time to understand its valuation trends.

Carisma Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Industry (0.00x)

September 17, 2025

Today (-0.62x)

September 17, 2025

Highest (-0.21x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.62x

Carisma Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Carisma Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Carisma Therapeutics Inc	BUY	$14.5M	NA	-0.62	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Carisma Therapeutics Inc Stock including INR - Dollar returns

The Carisma Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Carisma Therapeutics Inc investment value today

Current value as on today

₹36,598

Returns

₹63,402

(-63.4%)

Returns from Carisma Therapeutics Inc Stock

₹68,000 (-68%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Carisma Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Carisma Therapeutics Inc. Average target price of $1

Carisma Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Carisma Therapeutics Inc.

What analysts predicted

68%UPSIDE

Target Price

Current Price

$0.32

Analyzed by

12 Analysts

Target

$1.00

Carisma Therapeutics Inc target price $1, a slight upside of 68% compared to current price of $0.32. According to 12 analysts rating.

Carisma Therapeutics Inc Stock's Interest Amongst Investors

Investment in Carisma Therapeutics Inc Shares on INDmoney has grown by 386.66% over the past 30 days, indicating increased transactional activity.

Time period: August 19, 2025 to September 18, 2025

Change:386.66% versus previous 30 day period

Search interest for Carisma Therapeutics Inc Stock has increased by 309% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:309% versus previous 30 day period

Carisma Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	3	3	3	4	3	9	3	3	3	-
Gross Profit	2	2	3	-	1	8	3	2	3	0
Operating Income	-22	-20	-22	-22	-19	-11	-13	-17	-9	-5
EBITDA	-22	-20	-21	-	-17	-11	-12	-15	-8	-5
Interest Expense	1	-	-	-	0	0	-	-	-	-
Depreciation	0	0	0	0	1	0	0	0	0	-
Income Before Tax	-24	-19	-21	-21	-18	-11	-12	-17	-9	-9
Income Tax Expense	0	0	0	-	0	-	-	-	-	-
Net Income	-24	-19	-21	-20	-18	-11	-12	-17	-9	-9
Net Profit Margin	-759.85%	-558.31%	-559.26%	-488.65%	-558.67%	-121.37%	-375.24%	-482.75%	-248.48%	0.00%

Carisma Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	29	0	11	26	9	14	19
Gross Profit	0	29	0	11	26	3	-59	-40
Operating Income	-35	6	-19	-28	-40	-56	-88	-62
EBITDA	-31	2	-28	-27	-40	-51	-85	-57
Interest Expense	1	0	-	1	8	3	1	-
Depreciation	-	-	-	0	0	1	2	3
Income Before Tax	-33	1	-29	-28	-40	-61	-86	-60
Income Tax Expense	1	0	-	0	0	-3	8	-60
Net Income	-33	1	-29	-28	-40	-61	-86	-60
Net Profit Margin	-3378.99%	6.31%	-6830.35%	-252.31%	-153.65%	-622.60%	-582.34%	-308.05%

Carisma Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-19	-21	-20	-18	-11	-12	-17	-9	-9
Operating Cash Flow	-18	-20	-16	-22	-16	-13	-8	-10	-5
Investing Cash Flow	35	29	-	0	0	-56	-	0	0
Financing Cash Flow	-3	-2	0	1	0	0	0	0	-
Change in Cash	13	6	-5	-21	-16	-13	-8	-10	-5

Carisma Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	1	-29	-33	-107	-28	-40	-61	-86	-60
Operating Cash Flow	2	-17	-22	-37	-27	-37	-7	-81	-59
Investing Cash Flow	0	0	0	0	0	-1	-32	72	0
Financing Cash Flow	-13	7	58	35	72	15	35	62	0
Change in Cash	-10	-10	35	-2	44	-23	-138	53	-59

Insights on Carisma Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 3.38M → 3.72M (in $), with an average increase of 4.7% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 135.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CARM stock has moved down by -10.7%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -9.26M → -9.77M (in $), with an average decrease of 5.5% per quarter

About Carisma Therapeutics Inc

eleven biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease. eleven biotherapeutics' scientists are engineering protein-based drugs using newly available structural information and the company’s unique molecular understanding of clinical effects to create the next generation of protein-based medicines to treat important diseases with unmet needs, such as inflammatory conditions and coagulation disorders.

Organisation	Carisma Therapeutics Inc
Headquarters	3675 Market Street, Philadelphia, PA, United States, 19104
CEO	Mr. Steven Kelly
E-voting on shares	Click here to vote

Key Management of Carisma Therapeutics Inc

Name	Title
Ms. Natalie McAndrew	Vice President of Finance
Mr. Steven Kelly	President, CEO & Director
Mr. Michael Klichinsky Ph.D., Pharm.D., PharmD	Co-Founder & Chief Scientific Officer
Dr. Saar Gill M.D., Ph.D.	Co-Founder & Chairman of Scientific Advisory Board

FAQs

What is Carisma Therapeutics Inc share price today?

Carisma Therapeutics Inc share price today is $0.32 as on September 18, 2025 at 1:29 am IST at the close of the market. Carisma Therapeutics Inc share today touched a day high of $0.34 and a low of $0.31.

What is the 52 week high and 52 week low for Carisma Therapeutics Inc share?

Carisma Therapeutics Inc share touched a 52 week high of $1.27 on June 10, 2025 and a 52 week low of $0.14 on May 16, 2025. Carisma Therapeutics Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $0.32,which is 74.80% down from its 52 week high and 125.83% up from its 52 week low.

What is Carisma Therapeutics Inc's market capitalisation today?

Carisma Therapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Carisma Therapeutics Inc Stock (CARM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Carisma Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Carisma Therapeutics Inc Shares that will get you 4.6875 shares as per Carisma Therapeutics Inc share price of $0.32 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Carisma Therapeutics Inc Stock (CARM) from India?

Indian investors can start investing in Carisma Therapeutics Inc (CARM) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 9:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Carisma Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 9:44 am IST). Based on Carisma Therapeutics Inc share’s latest price of $0.32 as on September 18, 2025 at 1:29 am IST, you will get 31.2500 shares of Carisma Therapeutics Inc. Learn more about fractional shares .